Oscar Arrieta

Oscar Arrieta

Universidad Nacional Autónoma de México - Mexico City / Mexico
Medical and Health Sciences / Thoracic Surgery
AD Scientific Index ID: 811082
National Autonomous University of Mexico
person_outline Oscar Arrieta's MOST POPULAR ARTICLES
1-) Nivolumab versus docetaxel in advanced nonsquamous non–small-cell lung cancer New England Journal of Medicine 373 (17), 1627-1639, 2015
2-) Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial. Lancet 373 (9674), 1525-1531, 2009
3-) Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy … The Lancet 384 (9944), 665-673, 2014
4-) Nivolumab versus docetaxel in previously treated patients with advanced non–small-cell lung cancer: two-year outcomes from two randomized, open-label, phase III trials … Journal of clinical oncology 35 (35), 3924-3933, 2017
5-) Five-year outcomes from the randomized, phase III trials checkmate 017 and 057: nivolumab versus docetaxel in previously treated non–small-cell lung cancer Journal of Clinical Oncology 39 (7), 723-733, 2021